Thank you for writing to us. One of our executive will reach back to you through your submitted medium. In case there’s an urgency, feel free to connect over WhatsApp for faster response.
Prefer calling? Dial +918265041513 (International callers) or +918265041513 (Indian callers).
Azithral 500mg (Azithromycin) Darwin — STI, Tropical & Respiratory Infections Northern Territory Aus
6a6c3d6187041f67b87e6b91"
Azithral 500mg (Azithromycin) Darwin — STI, Tropical &
Respiratory Infections | Northern Territory, Australia (2026)
Product Name
Azithral 500mg Tablets
Product Details
Azithral 500mg contains Azithromycin 500mg, a broad-spectrum macrolide antibiotic used to treat a wide variety of bacterial infections. It works by inhibiting bacterial protein synthesis, preventing the growth and multiplication of susceptible bacteria.
Azithral is commonly prescribed for respiratory tract infections, skin and soft tissue infections, ear infections, certain sexually transmitted infections (STIs), and selected tropical bacterial infections. It is valued for its convenient once-daily dosing and short treatment duration.
Note: Azithromycin should only be used for bacterial infections and under the supervision of a qualified healthcare professional.
Store below 25°C in a cool, dry place away from direct sunlight
Manufacturer
Alembic Pharmaceuticals Ltd. (Brand may vary by market.)
Key Features
Contains Azithromycin 500mg.
Broad-spectrum macrolide antibiotic.
Convenient once-daily dosing.
Short treatment duration for many infections.
Effective against numerous respiratory bacterial pathogens.
Commonly prescribed for uncomplicated Chlamydia trachomatis infections according to local clinical guidance.
High tissue penetration with prolonged therapeutic activity.
Suitable for adult patients when prescribed by a healthcare professional.
Manufactured under stringent pharmaceutical quality standards.
Industry Update
Darwin and the Northern Territory continue to experience demand for effective antibiotics due to respiratory infections, remote healthcare challenges, and tropical infectious diseases. Healthcare providers emphasize antibiotic stewardship, recommending azithromycin only when clinically indicated to help reduce antimicrobial resistance.
Azithromycin remains an established treatment option for several bacterial respiratory infections and uncomplicated Chlamydia trachomatis infections where appropriate. However, Australian prescribing guidelines stress that it should not be relied upon as sole treatment for gonorrhoea or syphilis, and appropriate testing and guideline-based therapy are recommended.
In Northern Australia, ongoing public health efforts focus on improving access to timely diagnosis, antimicrobial stewardship, and infection prevention in remote communities. Healthcare providers continue to encourage appropriate prescribing practices to preserve antibiotic effectiveness while ensuring patients receive evidence-based treatment for bacterial infections.